Literature DB >> 17005855

GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing.

Christine A F von Arnim1, Robert Spoelgen, Ithan D Peltan, Meihua Deng, Stephanie Courchesne, Mirjam Koker, Toshifumi Matsui, Hisatomo Kowa, Stefan F Lichtenthaler, Michael C Irizarry, Bradley T Hyman.   

Abstract

The beta-amyloid (Abeta) precursor protein (APP) is cleaved sequentially by beta-site of APP-cleaving enzyme (BACE) and gamma-secretase to release the Abeta peptides that accumulate in plaques in Alzheimer's disease (AD). GGA1, a member of the Golgi-localized gamma-ear-containing ARF-binding (GGA) protein family, interacts with BACE and influences its subcellular distribution. We now report that overexpression of GGA1 in cells increased the APP C-terminal fragment resulting from beta-cleavage but surprisingly reduced Abeta. GGA1 confined APP to the Golgi, in which fluorescence resonance energy transfer analyses suggest that the proteins come into close proximity. GGA1 blunted only APP but not notch intracellular domain release. These results suggest that GGA1 prevented APP beta-cleavage products from becoming substrates for gamma-secretase. Direct binding of GGA1 to BACE was not required for these effects, but the integrity of the GAT (GGA1 and TOM) domain of GGA1 was. GGA1 may act as a specific spatial switch influencing APP trafficking and processing, so that APP-GGA1 interactions may have pathophysiological relevance in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005855      PMCID: PMC6674476          DOI: 10.1523/JNEUROSCI.2290-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  24 in total

Review 1.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 2.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

3.  BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin.

Authors:  Gina M Finan; Hirokazu Okada; Tae-Wan Kim
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

Review 4.  Autophagy modulation for Alzheimer's disease therapy.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

5.  Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.

Authors:  Gururaj Joshi; Kok Ann Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Neurobiol Aging       Date:  2014-09-06       Impact factor: 4.673

Review 6.  Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease.

Authors:  Gunjan Joshi; Yanzhuang Wang
Journal:  Bioessays       Date:  2014-12-28       Impact factor: 4.345

Review 7.  Neuronal protein trafficking associated with Alzheimer disease: from APP and BACE1 to glutamate receptors.

Authors:  Bor Luen Tang
Journal:  Cell Adh Migr       Date:  2009-01-21       Impact factor: 3.405

8.  Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1.

Authors:  Kendall R Walker; Eugene L Kang; Michael J Whalen; Yong Shen; Giuseppina Tesco
Journal:  J Neurosci       Date:  2012-07-25       Impact factor: 6.167

9.  Expression and processing of fluorescent fusion proteins of amyloid precursor protein (APP).

Authors:  Kathleen Coughlan; Xiangping Huang; Xiangyuan He; Charlotte H Y Chung; Guangpu Li; Jordan Tang
Journal:  Biochim Biophys Acta       Date:  2013-03-19

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.